Product Name | MF | CAS | Details |
---|
(2R)-1-(tert-butylamino)-3-{[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy}propan-2-ol, but-2-enedioic acid, 10 mM in DMSO | C17H28N4O7S | 1214981-81-3 | Details |
BMS-1166-N-piperidine-CO-N-piperazine dihydrochloride | C41H44Cl2N4O5 | 2691796-83-3 | Details |
T-5224, 10 mM in DMSO | C29H27NO8 | 530141-72-1 | Details |
(2-methyl-2,3-dihydro-1H-inden-2-yl)methanamine hydrochloride, 10 mM in DMSO | C11H16ClN | 129766-97-8 | Details |
(4R)-3-[2-(4-chlorophenoxy)-2-methylpropanoyl]-1,3-thiazolidine-4-carboxylic acid, 10 mM in DMSO | C14H16ClNO4S | 1307909-30-3 | Details |
hSMG-1 inhibitor 11e, 10 mM in DMSO | C26H27N7O3S | 1402452-10-1 | Details |
Glutathione arsenoxide hydrochloride, 10 mM in DMSO | Details |
SMANT hydrochloride | C16H24BrClN2O | 1177600-74-6 | Details |
MK-4827 Racemate, 10 mM in DMSO | C19H20N4O | 1038915-75-1 | Details |
rel-(8R,8''R)-Dimethyl-(7S,7''R)-bis(3,4-methylenedioxyphenyl)tetrahydro-furan | C20H20O5 | 178740-32-4 | Details |
6,7-dimethoxy-N-(4-nitrophenyl)quinazoli | C16H14N4O4 | 765899-28-3 | Details |
5-amino-1-[4-(trifluoromethyl)phenyl]-1H-pyrazole-4-carbonitrile, 10 mM in DMSO | C11H7F3N4 | 80025-67-8 | Details |
tert-Butyl ((3-hydroxyazetidin-3-yl)methyl)carbamate, 10 mM in DMSO | C9H18N2O3 | 1035351-07-5 | Details |
Pomalidomide-PEG1-CO2H | C18H19N3O7 | 2139348-60-8 | Details |
1-[4-(2,3-dihydro-1,4-benzodioxine-6-sulfonyl)piperazin-1-yl]-2-(6-methyl-1-benzofuran-3-yl)ethan-1-one | C23H24N2O6S | 847939-23-5 | Details |
1-[10-(pyridin-1-ium-1-yl)decyl]pyridin-1-ium dibromide | C20H30N2.2Br | 6266-40-6 | Details |
4-(2-fluorophenyl)-2,3-dihydro-1,3-thiazol-2-one, 10 mM in DMSO | C9H6FNOS | 1095051-79-8 | Details |
2-({[2-(4-ethoxy-3-methoxyphenyl)-1,3-thiazol-4-yl]methyl}sulfanyl)pyrimidine-4,6-diamine, 10 mM in DMSO | C17H19N5O2S2 | 1209784-87-1 | Details |
2-(4-methoxyphenyl)-2-oxoethyl 2-hydroxy-5-methylbenzoate, 10 mM in DMSO | C17H16O5 | 1197834-98-2 | Details |
4-(3-chlorophenyl)-2,3-dihydro-1,3-thiazol-2-one, 10 mM in DMSO | C9H6ClNOS | 1095051-68-5 | Details |
Thalidomide-NH-CH2-COOH, 10 mM in DMSO | C15H13N3O6 | 927670-97-1 | Details |
(-)-Syringaresnol-4-O-β-D-apiofuranosyl-(1→2)-β-D-glucopyranoside, 10 mM in DMSO | C33H44O17 | 136997-64-3 | Details |
N-[2-(5-Chloro-1H-indol-3-yl)ethyl]-4''-cyanobiphenyl-2-carboxaMide, 10 mM in DMSO | C24H18ClN3O | 1383373-65-6 | Details |
T-3775440 hydrochloride, 10 mM in DMSO | C18H23ClN4O | 1422535-52-1 | Details |
3-(2,6-dichlorophenyl)-1-methyl-7-(methylsulfanyl)-1H,2H,3H,4H-pyrimido[4,5-d][1,3]diazin-4-one, 10 mM in DMSO | C14H12Cl2N4OS | 1799561-19-5 | Details |
2-[(2S,5S)-5-(carbamoylmethyl)-3,6-dioxopiperazin-2-yl]acetamide, 10 mM in DMSO | C8H12N4O4 | 88206-98-8 | Details |
Phentolamine acetate, 10 mM in DMSO | C19H23N3O3 | 249607-96-3 | Details |
2-(5,7-dichloro-1H-indol-3-yl)ethan-1-amine | C10H10Cl2N2 | 2447-23-6 | Details |
2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine, 10 mM in DMSO | C20H19N3 | 237402-29-8 | Details |
1,1''-(Octane-1,8-diyl)diguanidine dihydrochloride, 10 mM in DMSO | C10H26Cl2N6 | 25303-05-3 | Details |
5-[(1S,2S)-2-[(Cyclopropylmethyl)amino]cyclopropyl]-N-(tetrahydro-2H-pyran-4-yl)thiophene-3-carboxamide hydrochloride | 1818253-48-3 | Details |
T56-LIMKi, 10 mM in DMSO | C19H14F3N3O3 | 924473-59-6 | Details |
T-3364366, 10 mM in DMSO | C18H16F3N3O3S2 | 1356354-09-0 | Details |
1-(3-chloropyridin-2-yl)piperazine dihydrochloride, 10 mM in DMSO | C9H13Cl2N3 | 1193389-39-7 | Details |
2,5-dichloro-4-(difluoromethoxy)-N,N-dimethylbenzene-1-sulfonamide, 10 mM in DMSO | C9H9Cl2F2NO3S | 473477-26-8 | Details |
5-(2-aminoethyl)-4-methyl-1,3-thiazol-2-amine dihydrochloride | C6H12ClN3S | 136604-58-5 | Details |
4-(4,5-dibromo-6-oxo-1,6-dihydropyridazin-1-yl)benzene-1-sulfonamide, 10 mM in DMSO | C10H7Br2N3O3S | 2163817-03-4 | Details |
(2E)-N-(4-methoxyphenyl)-3-[3-(4-methylphenyl)-1-phenyl-1H-pyrazol-4-yl]prop-2-enamide, 10 mM in DMSO | C26H23N3O2 | 380463-49-0 | Details |
3-amino-1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]propan-1-one dihydrochloride, 10 mM i | C25H28ClN7O2 | 2411178-94-2 | Details |
Glutathione arsenoxide hydrochloride | Details |
16beta-Methyl-16alpha,17alpha-epoxypregnenolone | C22H32O3 | 1922-48-1 | Details |
Protein kinase inhibitors 1 hydrochlorid, 10 mM in DMSO | Details |
m-Nisoldipine, 10 mM in DMSO | C20H24N2O6 | 113578-26-0 | Details |
8-Fluoro-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one | C11H9FN2O | 1408282-26-7 | Details |
7-Methyl-6-mercaptopurine, 10 mM in DMSO | C6H6N4S | 3324-79-6 | Details |
T3Inh-1, 10 mM in DMSO | C27H20N6O3 | 50440-30-7 | Details |
N-(2-hydroxyethyl)-Naphthalimide | C14H11NO3 | 5450-40-8 | Details |
Pomalidomide-PEG2-CO2H | C20H23N3O8 | 2140807-17-4 | Details |
N-(4-bromo-2-chlorophenyl)-5-chloro-2-hydroxybenzamide, 10 mM in DMSO | C13H8BrCl2NO2 | 1098360-68-9 | Details |
(2E)-3-(3,5-dimethoxyphenyl)-1-(2-methoxyphenyl)prop-2-en-1-one, 10 mM in DMSO | C18H18O4 | 1262887-77-3 | Details |
EM-12, 10 mM in DMSO | C13H12N2O3 | 26581-81-7 | Details |
1,3-dimethyl-2-oxobenzimidazole-5-carbaldehyde | C10H10N2O2 | 55241-49-1 | Details |
DL-Willardiine | C7H9N3O4 | 19772-76-0 | Details |
Ophiogenin 3-O-α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranoside | C39H62O14 | 128502-94-3 | Details |
T2AA, 10 mM in DMSO | C15H16ClI2NO3 | 1380782-27-3 | Details |
1-(cyclohexylmethyl)guanidine hydroiodide, 10 mM in DMSO | C8H18IN3 | 1376324-09-2 | Details |
NHS-PEG1-SS-PEG1-NHS, 10 mM in DMSO | C14H16N2O10S2 | 1688598-83-5 | Details |
2-(2-amino-3-methylbutanamido)-3-phenylpropanoic acid hydrochloride, 10 mM in DMSO | C14H21ClN2O3 | 128090-87-9 | Details |
N-Acetyl lysyltyrosylcysteine amide | C20H31N5O5S | 1287585-40-3 | Details |
Butanoic acid, 4-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]- | C17H17N3O6 | 2225940-47-4 | Details |
GNF-8625 monopyridin-N-piperazine hydrochloride | 2412055-62-8 | Details |
2H-Naphth[2′,1′:4,5]indeno[1,2-d][1,3]dioxole, pregn-4-ene-3,20-dione deriv | C25H34F2O6 | 144459-71-2 | Details |
1-(1-phenyltetrazol-5-yl)piperazine,hydrochloride, 10 mM in DMSO | C11H15ClN6 | 1171471-37-6 | Details |
T-26c, 10 mM in DMSO | C24H21N3O6S | 869296-13-9 | Details |
1,3,3,5,5-pentamethylcyclohexan-1-amine hydrochloride, 10 mM in DMSO | C11H24ClN | 209185-99-9 | Details |
ethyl 2-[3,5-bis(trifluoromethyl)phenyl]-3-oxo-2,3-dihydro-1H-pyrazole-4-carboxylate, 10 mM in DMSO | C14H10F6N2O3 | 1878204-21-7 | Details |
1,1''-(Heptane-1,7-diyl)diguanidine dihydrochloride, 10 mM in DMSO | 2193061-39-9 | Details |
(S)-ABT 102, 10 mM in DMSO | C21H24N4O | 808756-70-9 | Details |
GV-150013X, 10 mM in DMSO | C33H34N4O3 | 151386-96-8 | Details |
Geranylgeranyl pyrophosphate tetrabutylammonium(1:1.5) | Details |
1-((3R,4S)-3-hydroxy-2,2-dimethyl-6-(phenylsulfonyl)chroman-4-yl)pyrrolidin-2-one | 184653-89-2 | Details |
3-(3,6-dichloro-9H-carbazol-9-yl)propanoic acid, 10 mM in DMSO | C15H11Cl2NO2 | 300816-42-6 | Details |
INCB032304, 10 mM in DMSO | C15H21N5OSi | 941685-27-4 | Details |
GLP-1R Agonist DMB | C13H15Cl2N3O2S | 281209-71-0 | Details |
1-(2,4-difluorophenyl)guanidine hydrochloride, 10 mM in DMSO | C7H8ClF2N3 | 112677-40-4 | Details |
1-{1H-pyrrolo[2,3-d]pyrimidin-4-yl}piperazine dihydrochloride | C10H14ClN5 | 853680-06-5 | Details |
1-ethyl-6-fluoro-4-oxo-7-[4-(3-phenylpropanoyl)piperazin-1-yl]-1,4-dihydroquinoline-3-carboxylic acid | C25H26FN3O4 | 924198-81-2 | Details |
ethyl 1-(4-aminophenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate, 10 mM in DMSO | C13H12F3N3O2 | 223500-15-0 | Details |
2,3-dihydroxy-3-methylbutanoic acid, 10 mM in DMSO | C5H10O4 | 1756-18-9 | Details |
(2-methylpropyl)({[3-(trifluoromethyl)phenyl]methyl})amine, 10 mM in DMSO | C12H16F3N | 912291-11-3 | Details |
Methyl 2-(Boc-aMino)-2-(oxetan-3-yl)acetate, 10 mM in DMSO | C11H19NO5 | 1416323-08-4 | Details |
2-methyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one | C10H11NOS | 96680-77-2 | Details |
T521 | C17H14FNO5S2 | 891020-54-5 | Details |
3-phenoxy-8-azabicyclo[3.2.1]octane hydrochloride, 10 mM in DMSO | C13H18ClNO | 1955540-15-4 | Details |
diABZI STING agonist-1 trihydrochloride | C42H52ClN13O7 | 2138299-34-8 | Details |
N-(2-{bis[2-(2,2-dichloroacetamido)ethyl]amino}ethyl)-2,2-dichloroacetamide hydrochloride, 10 mM in DMSO | 2193060-78-3 | Details |
Thalidomide-5-NH2-CH2-COOH | C15H13N3O6 | 2412056-27-8 | Details |
Protein kinase inhibitors 1 hydrochlorid | Details |
Benzonitrile, 4-[[5-cyclopropyl-3-methyl-1-[(methylsulfonyl)methyl]-1H-pyrazol-4-yl]oxy]-2,6-dimethyl-, 10 mM in DMSO | C18H21N3O3S | 936345-34-5 | Details |
3-hydroxy-3-phenylpentanamide, 10 mM in DMSO | C11H15NO2 | 131802-69-2 | Details |
1,2-diphenylpropan-2-amine, 10 mM in DMSO | C15H17N | 118910-28-4 | Details |
6-ethyl-7-hydroxy-4-methylchromen-2-one | C12H12O3 | 1484-73-7 | Details |
sodium 3-amino-4,6-dimethylthieno[2,3-b]pyridine-2-carboxylate, 10 mM in DMSO | C10H9N2NaO2S | 144254-93-3 | Details |
7-benzyl-5,6-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine | C15H16N4 | 56344-53-7 | Details |
4-[(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]benzoic acid, 10 mM in DMSO | C11H7NO4S | 199167-79-8 | Details |
Pinocembrin 7-O-[3''''-O-galloyl-4'''',6''''-hexahydroxydiphenoyl]-β-D-glucoside | C42H32O21 | 205370-59-8 | Details |
5-Bromo-4-chloro-3-indoxyl-beta-D-cellobioside, 10 mM in DMSO | C20H25BrClNO11 | 177966-52-8 | Details |
4-Bromo-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione | C13H9BrN2O4 | 2093536-12-8 | Details |
Suc-Leu-Tyr-AMC | C29H33N3O8 | 94367-20-1 | Details |
12-oxo-N-[1-(propan-2-yl)piperidin-4-yl]-6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide | C22H30N4O2 | 918328-92-4 | Details |
Product Total: Product Page: | ||||
196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 |